Financial Reporting
Is a SAFE Debt or Equity? Why the Valuation Cap Usually Pushes It Into Liabilities
FASB never wrote a SAFE standard. Your valuation cap divided by capitalization fails the fixed-for-fixed test, and that usually lands the SAFE in liabilities.
By 409.AI Team - 2026-09-15
# Is a SAFE Debt or Equity? Why the Valuation Cap Usually Pushes It Into Liabilities
You raised $2 million on SAFEs last year. No interest rate, no maturity date, no repayment. Nothing about the document feels like debt, and the whole point of the instrument was to skip the negotiation that a priced round forces. Then your first audited balance sheet comes back and that $2 million is sitting in liabilities, with a fair value loss running through your income statement because the company got more valuable.
Founders treat this as an auditor being difficult. It usually isn't. It's the predictable output of two pieces of U.S. GAAP that were written long before the SAFE existed, applied to a settlement clause most founders have never read closely.
There is no SAFE standard
The FASB has never issued guidance specific to simple agreements for future equity. That absence is the root of everything else. Because no standard names the instrument, the accounting is driven entirely by what your particular document says it will do, and an issuer has to work through the general guidance on equity-linked contracts instead.
The order is fixed. First you identify the unit of account: is the SAFE one freestanding financial instrument, or does the deal contain several? Then you test it under ASC 480, *Distinguishing Liabilities from Equity*. Only if it survives ASC 480 do you move to ASC 815-40, *Contracts in Entity's Own Equity*. Grant Thornton's [Viewpoint on issuers' accounting for SAFEs](https://www.grantthornton.com/insights/newsletters/audit/2024/viewpoint/issuers-accounting-for-safe) walks the full sequence, and its practical observation is worth repeating: liability classification is common, but an issuer cannot presume it. The analysis has to be done step by step, on your document.
One shortcut that founders and controllers reach for doesn't work either. You can't elect the fair value option in ASC 825 at the outset to avoid the classification work. The fair value option isn't available for equity, so you have to know where the SAFE lands before you know whether the election is even on the table. By then, if the answer is liability, you're measuring it at fair value anyway.
ASC 480: the obligations that settle in a fixed amount
ASC 480 catches instruments that are equity in form but obligations in substance. Two tests matter for SAFEs.
The first, in ASC 480-10-25-8, covers an obligation to repurchase the issuer's own shares by transferring assets. The second, ASC 480-10-25-14, is the one that catches more SAFEs. It applies when an issuer must or may settle in a *variable number of shares* whose monetary value is based predominantly on any of three things: a fixed monetary amount known at inception, variations in something other than the fair value of the issuer's shares, or variations inversely related to the fair value of the issuer's shares.
Read your change-of-control clause with that test in hand. A common SAFE provision says that on an acquisition the investor gets back the purchase amount, at their election, in shares. Call it $2 million of value delivered in however many shares it takes. The number of shares floats; the dollars don't. ASC 480-10-55-22 illustrates exactly this pattern with an entity that receives $100,000 and promises enough of its own shares to be worth $110,000 at a future date, and concludes the instrument is a liability under 480-10-25-14(a). A small amount of variability doesn't save it. The example makes the point with an averaging mechanic: even where the share count is struck off a 30-day average rather than the settlement-date price, the obligation is still predominantly a fixed monetary amount.
Most SAFEs embody more than one obligation, which is where the word "predominantly" earns its keep. ASC 480-10-55-42 and 55-43 direct the issuer to assess predominance at contract inception, by weighing the likelihood of each settlement outcome against the others in that instrument, not against every outcome imaginable. A SAFE that will almost certainly convert in a priced round, and pays a fixed dollar amount only in a remote acquisition scenario, can reach a different answer than one written for a company already fielding acquisition interest.
ASC 815-40: where the valuation cap does the damage
A SAFE that clears ASC 480 still has to be indexed to the company's own stock and meet the equity classification conditions. ASC 815-40-15-7 sets out a two-step approach: evaluate the exercise contingencies, then evaluate the settlement provisions.
Step one is rarely the problem. An exercise contingency only breaks indexation if it's based on an observable market other than the market for the issuer's stock, or an observable index that isn't calculated by reference to the issuer's own operations. "Converts on a qualified equity financing" and "converts on an IPO" are entity-specific events. ASC 815-40-55-26 works through warrants that become exercisable only when the issuer completes an IPO and concludes they're still indexed to the entity's own stock.
Step two is where SAFEs come apart, and the culprit is the term founders negotiate hardest.
The settlement provision has to be fixed-for-fixed: the settlement amount equals the difference between the fair value of a *fixed number* of shares and a *fixed monetary amount*, per ASC 815-40-15-7C. Terms can adjust the strike price or the share count without breaking this, but only if the variables driving the adjustment are inputs to a fixed-for-fixed option pricing model. ASC 815-40-15-7E lists what those inputs look like: strike price, term, expected dividends and other dilutive activity, stock borrow cost, interest rates, volatility, the entity's credit spread, and the ability to maintain a standard hedge position.
Now look at how a post-money SAFE actually converts. The price per share is the valuation cap divided by the company's capitalization: the share count outstanding at conversion, on a fully or partly diluted basis. Your share count is not on that list, and it isn't a fixed-for-fixed input. Every option you grant, every SAFE you issue before conversion, moves the divisor and therefore moves the number of shares the holder receives. Settlement provisions built on a valuation cap divided by capitalization typically fail the fixed-for-fixed criterion, which means the SAFE isn't indexed to your own stock, which means liability.
That conclusion surprises people because two features that *feel* riskier are fine. Standard antidilution adjustments, the kind that protect a holder from a stock split or a stock dividend, don't preclude fixed-for-fixed treatment. Neither does a down round feature on its own; ASC 815-40-15-5D addresses it directly. The provision that sinks the analysis is the ordinary arithmetic of a [Y Combinator post-money SAFE](https://www.ycombinator.com/documents).
There's a second trapdoor in the equity classification conditions of ASC 815-40-25. If your SAFE requires cash settlement on a change of control that the company doesn't control, and your common holders wouldn't receive cash for their shares in that same event, the instrument fails the equity conditions and lands in liabilities regardless of how the indexation analysis came out.
What liability classification actually costs you
A liability-classified SAFE is measured initially at fair value, under ASC 480-10-30-7 or ASC 815-40-30-1 depending on which subtopic caught it. Then it's remeasured at fair value every reporting period, with the change running through earnings, under ASC 480-10-35-5 or ASC 815-40-35-4. The measurement guidance ends up in the same place either way.
Work the numbers. You take $2 million in January on a $20 million post-money cap. By December you've signed a term sheet at $60 million pre-money. The SAFE holder's claim is worth substantially more than the $2 million they wired, because they convert at the cap. That increase isn't a footnote. It's a fair value loss in your income statement, in the year you had your best results, and the liability on your balance sheet grows with it. A company with $2 million of SAFEs, modest equity, and a good year can report negative stockholders' equity and a net loss larger than its cash burn.
Equity classification is the quieter outcome. Contracts classified in permanent equity aren't remeasured while they stay there, per ASC 815-40-35-2, though ASC 815-40-35-8 requires you to reassess classification at each reporting date.
The remeasurement is also real valuation work. Determining what a SAFE is worth at December 31 means modeling the settlement outcomes and the equity value underneath them, which draws on the same apparatus as a [409A allocation: an option pricing model, a backsolve to the last round](https://409.ai/articles/409a-allocation-methods-opm-pwerm-backsolve). It is not the same exercise, and your 409A report doesn't answer the question. A 409A prices common stock for a strike price; this prices the SAFE holder's claim for your financial statements. The inputs are unobservable, so the measurement lands in [Level 3 of the ASC 820 hierarchy](https://409.ai/articles/asc-820-level-3-classification-significant-unobservable-input) with the disclosure that comes with it. If you want the mechanics of splitting a hybrid instrument into pieces and valuing each, the [with-and-without method used for convertible notes](https://409.ai/articles/convertible-note-with-and-without-valuation-method) covers the closest analogue.
Why this is moving again
Practitioners have been telling the FASB the cost isn't worth it. At its September 12, 2023 meeting, the Private Company Council discussed SAFEs and the complexity of getting the classification right, and raised whether GAAP needs a practical expedient for an instrument that has become standard in early-stage financing.
Nothing has been issued. But the PCC's [public meeting agenda for June 1 and 2, 2026](https://storage.fasb.org/PCC%20Meeting%20PUBLIC%20Agenda%202026%2006%2001%2002%20.pdf) lists "Indexation: Debt and Equity" as a research topic, and indexation is precisely the fixed-for-fixed machinery described above. A private company research project isn't a standard, and it may not produce one. Until something changes, the guidance your auditor applies is the guidance that exists.
Before your first audit, read the settlement waterfall
Three things are worth doing now rather than in March.
Read each SAFE's settlement terms individually. Companies assume that because every document came off the same template, one conclusion covers the stack. It often doesn't. A side letter granting pro rata rights or MFN treatment can be a separate freestanding instrument with its own analysis, and a SAFE amended mid-life may need to be treated as a new instrument for accounting purposes.
Check the change-of-control clause specifically for cash. That single sentence can override an otherwise clean indexation conclusion.
Then budget for the recurring measurement, not just the first one. A liability-classified SAFE needs a fair value at every reporting date until it converts, which makes it an ongoing [ASC 820 fair value engagement](https://409.ai/products/asc-820) rather than a one-time calculation. That surprise is the one that shows up in [what your first audit tests](https://409.ai/articles/first-audit-409a-valuation-au-c-540-assumptions), when your auditor asks for the method and the significant assumptions behind a number nobody budgeted to produce.
None of this changes what the SAFE does commercially. The holder still converts into preferred stock at your next priced round, their [QSBS holding period still starts at conversion rather than at the wire](https://409.ai/articles/safes-qsbs-holding-period-conversion-section-1202), and your [409A still has to price the claim they hold over your common stock](https://409.ai/articles/how-safes-affect-your-409a-valuation). What changes is your financial statements, and the time to find that out is while you can still ask your accountant about a specific clause, not after the auditor has already booked it.